glp-1 gip therapy effectiveness benefits Tirzepatide in Sun City AZ: A Treatment for Weight Loss Tirzepatide is redefining obesity &

doi: 10.1038/onc.2015.178, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar] 94

This is the industry standard

Interestingly, both kinase DYRK1A and Akt have convergent effects by directly inactivating GSK3 by phosphorylation at Thr356 (for DYRK1A) (Song et al., 2015) and on serine 9 (for Akt) (Tlili et al., 2013

Keep in mind that supplements are made to support the body and not provide treatment like a medication

The reduction correlates with overall weight loss, typically 10-15% of body weight with higher-dose formulations

That is a clinically useful result for a short-term, low-cost agent but it is roughly half to a third of what semaglutide achieves over a longer horizon, and phentermine's effect is studied over a much shorter window